CAC (CAC40.NDX)

Close: 7 502.78 (+20.42), Apr 24, 2025
Weak Negative

Automatic technical analysis. Short term, Apr 24, 2025

Investors have accepted lower prices over time to get out of CAC and the index is in a falling trend channel in the short term. Falling trends indicate that the market experiences negative development and falling buy interest among investors. The index has support at points 7270 and resistance at points 8200. The index is assessed as technically slightly negative for the short term.

Recommendation one to six weeks: Weak Negative

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.70%0.00+0.27%
5 days0.002.18%0.00+2.28%
22 days0.005.61%0.00-6.72%
66 days0.0010.74%0.00-2.98%

More analyses of CAC

chart CAC (CAC40) Candlesticks 22 Days
Candlesticks
chart CAC (CAC40) Short term
Short term: Weak Negative
chart CAC (CAC40) Medium term
Medium term: Positive
chart CAC (CAC40) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.